A Novel Defined TLR3 Agonist as an Effective Vaccine Adjuvant

Synthetic double-stranded RNA analogs recognized by Toll-like receptor 3 (TLR3) are an attractive adjuvant candidate for vaccines, especially against intracellular pathogens or tumors, because of their ability to enhance T cell and antibody responses. Although poly(I:C) is a representative dsRNA with potent adjuvanticity, its clinical application has been limited due to heterogeneous molecular size, inconsistent activity, poor stability, and toxicity. To overcome these limitations, we developed a novel dsRNA-based TLR3 agonist named NexaVant (NVT) by using PCR-coupled bidirectional in vitro transcription. Agarose gel electrophoresis and reverse phase-HPLC analysis demonstrated that NVT is a single 275-kDa homogeneous molecule. NVT appears to be stable since its appearance, concentration, and molecular size were unaffected under 6 months of accelerated storage conditions. Moreover, preclinical evaluation of toxicity under good laboratory practices showed that NVT is a safe substance without any signs of serious toxicity. NVT stimulated TLR3 and increased the expression of viral nucleic acid sensors TLR3, MDA-5, and RIG-1. When intramuscularly injected into C57BL/6 mice, ovalbumin (OVA) plus NVT highly increased the migration of dendritic cells (DCs), macrophages, and neutrophils into inguinal lymph node (iLN) compared with OVA alone. In addition, NVT substantially induced the phenotypic markers of DC maturation and activation including MHC-II, CD40, CD80, and CD86 together with IFN-β production. Furthermore, NVT exhibited an appropriate adjuvanticity because it elevated OVA-specific IgG, in particular, higher levels of IgG2c (Th1-type) but lower IgG1 (Th2-type). Concomitantly, NVT increased the levels of Th1-type T cells such as IFN-γ+CD4+ and IFN-γ+CD8+ cells in response to OVA stimulation. Collectively, we suggest that NVT with appropriate safety and effectiveness is a novel and promising adjuvant for vaccines, especially those requiring T cell mediated immunity such as viral and cancer vaccines

Development of a new lactic acid bacterial inoculant for fresh rice straw silage

Objective Effects of newly isolated Lactobacillus plantarum on the fermentation and chemical composition of fresh rice straw silage was evaluated in this study. Methods Lactic acid bacteria (LAB) from good crop silage were screened by growing them in MRS broth and a minimal medium with low carbohydrate content. Selected LAB (LAB 1821) were Gram-positive, rods, catalase negative, and were identified to be Lactobacillus plantarum based on their biochemical characteristics and a 16S rRNA analysis. Fresh rice straw was ensiled with two isolated LAB (1821 and 1841), two commercial inoculants (HM/F and P1132) and no additive as a control. Results After 2 months of storage at ambient temperature, rice straw silages treated with additives were well-preserved, the pH values and butyric and acetic acid contents were lower, and the lactic acid content and lactic/acetic acid ratio were higher than those in the control (p0.05) effect on acid detergent fiber or neutral detergent fiber contents. Crude protein (CP) content and in vitro DM digestibility (IVDMD) increased after inoculation of LAB 1821 (p<0.05). Conclusion LAB 1821 increased the CP, IVDMD, lactic acid content and ratio of lactic acid to acetic acid in rice straw silage and decreased the pH, acetic acid, NH3-N, and butyric acid contents. Therefore, adding LAB 1821 improved the fermentation quality and feed value of rice straw silage

A Dalbergia odorifera extract improves the survival of endotoxemia model mice by inhibiting HMGB1 release

Abstract Background Dalbergia odorifera T. Chen (Leguminosae) is an indigenous medicinal herb that is widely used as a popular remedy in northern and eastern Asia. However, the cellular mechanisms underlying the biological activity of D. odorifera are not fully elucidated. Methods Anti-inflammatory effect of D. odorifera extract (DOE) was determined through intraperitoneal injection in a mouse model of endotoxemia induced by lipopolysaccharide (LPS). RAW 264.7 cells, a murine macrophage, were also treated with LPS to generate a cellular model of inflammation, and investigated the anti-inflammatory activity and underlying mechanisms of DOE and its constituent isoliquiritigenin. Results DOE dose-dependently inhibited LPS-induced release of high mobility group box 1 (HMGB1), a late proinflammatory cytokine, and decreased cytosolic translocation of HMGB1 in RAW264.7 cells. This inhibitory effect of DOE on HMGB1 release was observed in cells treated with DOE before or after LPS treatment, suggesting that DOE is effective for both treatment and prevention. In addition, DOE significantly inhibited LPS-induced formation of nitric oxide (NO) and expression of inducible NO synthase (iNOS) in a dose-dependent manner. These effects of DOE were accompanied by suppression of HMGB1 release triggered by LPS, suggesting a possible mechanism by which DOE modulates HMGB1 release through NO signaling. Isoriquiritigenin, a constituent of DOE, also attenuated LPS-triggered NO formation and HMGB1 release in RAW264.7 cells, indicating that isoriquiritigenin is an indexing molecule for the anti-inflammatory properties of DOE. Furthermore, c-Jun N-terminal kinase, but not extracellular signal-regulated kinase and p38, mediated DOE-dependent inhibition of HMGB1 release and NO/iNOS induction in RAW 264.7 cells exposed to LPS. Notably, administration of DOE ameliorated survival rates in a mouse model of endotoxemia induced by LPS, where decreased level of circulating HMGB1 was observed. Conclusion These results suggest that DOE confers resistance to LPS-triggered inflammation through NO-mediated inhibitory effects on HMGB1 release

Effect of Se modification on RuSey/C electrocatalyst for oxygen reduction with phosphoric acid

Carbon-supported Se-modified-Ru catalysts (RuSey/C) were synthesized, and their phosphate adsorption characteristics were evaluated using electrochemical techniques and in-situ X-ray absorption spectroscopy (XAS). When phosphoric acid was added, the ORR activity of unmodified Ru/C decreased by 26.8% because the active sites were blocked by electrochemical adsorption, as confirmed by CV. However, for RuSey/C, the ORR activity was enhanced with phosphoric acid (RuSe1.56/C: 63.8%), which indicates that the kinetics at each site increased to compensate for the site blocking effect. The XAS results demonstrated that, for RuSey/C, phosphoric acid molecules or phosphate anions primarily interacted with Se atoms, and the oxidation state of Ru atoms decreased. Therefore, it was concluded that the enhanced ORR kinetics originated from the decreased oxygen binding energy with larger electrostatic repulsion. Keywords: Se-modified-Ru catalyst, Oxygen reduction reaction, Phosphoric acid, High temperature-PEMF

Effect of Se modification on RuSey/C electrocatalyst for oxygen reduction with phosphoric acid

Carbon-supported Se-modified-Ru catalysts (RuSey/C) were synthesized, and their phosphate adsorption characteristics were evaluated using electrochemical techniques and in-situ X-ray absorption spectroscopy (XAS). When phosphoric acid was added, the ORR activity of unmodified Ru/C decreased by 26.8% because the active sites were blocked by electrochemical adsorption, as confirmed by CV. However, for RuSey/C, the ORR activity was enhanced with phosphoric acid (RuSe1.56/C: 63.8%), which indicates that the kinetics at each site increased to compensate for the site blocking effect. The XAS results demonstrated that, for RuSey/C, phosphoric acid molecules or phosphate anions primarily interacted with Se atoms, and the oxidation state of Ru atoms decreased. Therefore, it was concluded that the enhanced ORR kinetics originated from the decreased oxygen binding energy with larger electrostatic repulsion. © 2012 Elsevier B.V. All rights reserved.1441sciescopu